Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Vulvar Neoplasms 2Vaginal Neoplasms 2Uterine Cervical Neoplasms 2Sexual Dysfunction, Physiological 1Rectal Neoplasms 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Depression 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms 1Anxiety Disorders 1Anus Neoplasms 1

Interventions

Cyclophosphamide 8pembrolizumab 7fludarabine 6aldesleukin 4Papillomavirus Vaccines 4Vaccines 3Radiotherapy 3Light Coagulation 3Biopsy 3spartalizumab 2fludarabine phosphate 2entinostat 2Watchful Waiting 2Vorinostat 2VGX-3100 2Trastuzumab 2Tomography, X-Ray Computed 2Surveys and Questionnaires 2Paclitaxel 2Observation 2Nivolumab 2Interleukin-2 2Interleukin-12 Subunit p35 2Early Intervention, Educational 2Drug Therapy 2Carboplatin 2Adoptive Transfer 2trastuzumab deruxtecan 1tislelizumab 1tipifarnib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anus Neoplasms × Dehydroepiandrosterone × Gynecologic × Clear all
NCT07407647 2026-04-21

Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting
25 enrolled
GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms, Rectal Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡